Ovarian Cancer :: Experimental drug boosts survival in recurrent ovarian cancer patients
New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently.